...
首页> 外文期刊>BMC Musculoskeletal Disorders >Pretic-I was a safe and effective artificial cervical disc prosthesis--a retrospective and comparative study with 5-year follow-up
【24h】

Pretic-I was a safe and effective artificial cervical disc prosthesis--a retrospective and comparative study with 5-year follow-up

机译:Precet-i是一种安全有效的人工颈椎间盘假体 - 一种回顾性和比较研究,5年随访

获取原文

摘要

The newly designed cervical disc prosthesis, Pretic-I, had been finished its limited clinical use for over 5?years. At a short-term follow-up of 2?years, we obtained satisfactory clinical results. The long-term clinical efficacy and safety of Pretic-I will now be analyzed. Peri-operative parameters included intra-operative blood loss, operation time, off-bed time. Clinical parameters included visual analogue scale (VAS) for arm and neck, neck disability index (NDI), and Japanese Orthopaedic Association (JOA) score. Radiological parameters included C2–7 Cobb angle, Shell angle, and the range of motion (ROM) of C2–7, functional segment unit (FSU), and adjacent FSU. The CDA-related complications included adjacent segment degeneration (ASDeg), adjacent segment disease (ASDis), heterotopic ossification (HO), prosthesis subsidence, prosthesis displacement, and dysphagia. A total 64 patients from two independent centers received a single-level CDA with Discover (n?=?32) and Pretic-I (n?=?32), and all of patients finished a 5-year follow-up. There’re no significant differences between two groups in peri-operative parameters. The clinical parameters improved greatly in Pretic-I group (p0.0001), and there’s no statistical difference from Discover group. Furthermore, Pretic-I could slightly improve the cervical curvature (15.08?±?11.75 to 18.00?±?10.61, p?=?0.3079) and perfectly maintain the Shell angle (3.03?±?3.68 to 2.23?±?4.10, p?=?0.1988), cervical ROM (52.48?±?14.31 to 53.30?±?11.71, p?=?0.8062) and FSU ROM (12.20?±?4.52 to 10.73?±?4.45, p?=?0.2002). The incidence of high-grade HO (Grade III-IV) at the final follow-up was significantly lower in Pretic-I group than in Discover group (12.50% vs. 34.38%, p?=?0.0389, Statistical Power?=?95.36%). The incidences of other CDA-related complications in Pretic-I group were also well-accepted, comparable to the Discover group, without significant differences. CDA with Pretic-I demonstrated a well-accepted and sustained clinical outcome, with a significantly lower incidence of high-grade HO. This newly designed prosthesis is expected to become an alternative choice for cervical disc prosthesis in the future.
机译:新设计的宫颈椎间盘假肢,Precet-i,已完成其有限的临床用途,超过5年。在短期后续2年,我们获得了令人满意的临床结果。现在将分析预防预防的长期临床疗效和安全性。 PERI操作参数包括血液损失,操作时间,脱床时间。临床参数包括用于臂和颈部,颈部残疾指数(NDI)和日本矫形协会(JOA)评分的视觉模拟量表(VAS)。放射线参数包括C2-7 Cobb角,壳角和C2-7,功能段单元(FSU)和相邻FSU的运动范围(ROM)。 CDA相关的并发症包括相邻的段变性(ASDEG),相邻的分段疾病(ASDIS),异位骨化(HO),假体沉降,假体位移和吞咽困难。来自两个独立中心的64名患者接受了一次性CDA,发现(n?=?32)和prectic-i(n?=?32),所有患者都完成了5年的随访。 PERI操作参数中的两组之间没有显着差异。 PRETIC-I组(P< 0.0001)中临床参数大大提高,探索组没有统计学差异。此外,prectic-i可以略微改善宫颈曲率(15.08?±11.75至18.00〜18.00?10.61,p?=?0.3079)并完美地保持壳体角度(3.03?±3.68至2.23?±4.10,p ?=?0.1988),宫颈rom(52.48?±14.31至53.30?±11.71,p?=?0.8062)和FSU ROM(12.20?±4.52至10.73?±4.45,p?= 0.2002)。 Prober-I组最终随访的HO(III-IV级)的发病率显着低于Discover Group(12.50%与34.38%,P?= 0.0389,统计功率?=? 95.36%)。 PRETIC-I组中其他CDA相关并发症的发生率也接受了很好的,与发现组相当,没有显着差异。 PRETIC-I的CDA证明了良好的临床结果,高档HO的发病率显着降低。这种新设计的假肢预计将成为未来宫颈椎间盘假体的替代选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号